Clinical Trial Update: Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating radiotherapy for BCG-unresponsive non-muscle-invasive bladder cancer in situ (CIS), with the trial cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Carcinoma in Situ of Bladder
• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Bladder Cancer | Phase 2 | Status: NOT_YET_RECRUITING